Causes of Lung Enlargement in a Baby Not Gaining Weight
Lung enlargement in a baby with failure to thrive is most commonly caused by chronic lung disease of infancy (CLDI), where pulmonary hyperinflation develops as a compensatory mechanism to maintain adequate oxygenation despite underlying respiratory pathology. 1
Primary Pathophysiological Mechanisms
Pulmonary Causes
Air trapping and hyperinflation:
- Excessive central airway collapsibility leads to abnormal expiratory flow, air trapping, and hypoxemia
- Over time, pulmonary fibrosis becomes less important relative to airway disease, causing lung volumes to increase disproportionately with growth 1
- Longitudinal studies show a shift from low to relatively high functional residual capacity (FRC) between ages 1-3 years
Chronic inflammation and remodeling:
- Aspiration from gastroesophageal reflux or swallowing dysfunction causes pulmonary inflammation
- Recurrent infections lead to airway inflammation and bronchospasm
- These processes contribute to both hyperinflation and failure to thrive 1
Cardiac-Pulmonary Interactions
Left ventricular dysfunction:
- Increases lung water content
- Leads to increased airway resistance and decreased lung compliance
- Contributes to both lung enlargement and failure to thrive 1
Left atrial enlargement:
- Can compress the left main bronchus leading to atelectasis
- May cause development of airway malacia in the compressed segment
- Creates a cycle of worsening respiratory function 1
Nutritional-Pulmonary Interactions
Increased energy expenditure:
- Increased work of breathing diverts calories from growth
- Chronic inflammation increases metabolic demands
- Resting metabolic energy requirements are higher in infants with CLDI and growth failure 1
Poor nutrition effects on lung development:
- Delays lung, chest wall, and alveolar growth
- Impairs pulmonary healing
- Creates a vicious cycle where respiratory problems worsen nutritional status 1
Specific Clinical Entities to Consider
Chronic Lung Disease of Infancy (CLDI)/Bronchopulmonary Dysplasia
- Most common cause in premature infants
- Initially presents with low lung volumes that become normal or elevated later in infancy
- Specific compliance (corrected for body weight/lung volume) is 30-50% of normal values 1
Congenital Pulmonary Anomalies
- Bullous lung disease and emphysematous changes
- Can present with failure to thrive in infancy
- May be associated with genetic syndromes (e.g., Turner syndrome) 2
Neuroendocrine Cell Hyperplasia of Infancy (NEHI)
- Rare childhood interstitial lung disease
- Presents with tachypnea, hypoxemia, and failure to thrive in first 2 years
- Often misdiagnosed as recurrent bronchiolitis or reactive airway disease 3
Diagnostic Approach
Key Clinical Features to Assess
- Respiratory rate and work of breathing
- Growth parameters (weight, length, head circumference)
- Oxygen saturation (particularly during sleep and feeding)
- Signs of cardiac dysfunction (hepatomegaly, edema)
- Feeding difficulties and swallowing coordination
Important Diagnostic Tests
- Chest imaging (radiography and CT if needed)
- Echocardiogram to assess cardiac function and structure
- Pulmonary function testing (when feasible)
- Evaluation for gastroesophageal reflux and aspiration
- Nutritional assessment
Management Considerations
Breaking the Cycle
- Address both respiratory and nutritional needs simultaneously:
- Optimize respiratory support to decrease work of breathing
- Provide adequate calories (often 120-150% of normal requirements)
- Consider concentrated formulas if fluid restriction is needed 1
Common Pitfalls to Avoid
- Focusing only on respiratory management without addressing nutritional needs
- Attributing all symptoms to common conditions (like bronchiolitis) without considering rare diseases
- Failing to recognize the multisystem nature of conditions causing both lung enlargement and failure to thrive
- Inadequate caloric supplementation that doesn't account for increased metabolic demands
Early recognition and management of these interconnected problems is essential to improve outcomes and prevent long-term respiratory and developmental complications.